Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT04929405 |
Other study ID # |
UMCIRB 19-001984 |
Secondary ID |
|
Status |
Completed |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
March 3, 2021 |
Est. completion date |
December 31, 2021 |
Study information
Verified date |
March 2022 |
Source |
East Carolina University |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Parental bereavement experiences are unique and require interventions adaptable to individual
experiences.The web-based, multi-modal intervention, labeled ADAPT, incorporates varied
self-management strategies including: A: Asking for assistance (option to connect with
child's healthcare team); DA: Developing Adaptive ability (self-management tools: e.g. stress
reduction, legacy building); P: Accessing Pertinent online resources (grief support
networks/websites); and T: Tracking one's health (self-administered surveys for grief, sleep,
anxiety, and depression). A quasi-experimental, treatment-only design will be used for this
study. The hypothesis is that the ADAPT intervention will promote positive adaptation to
influence grief integration and consequently affect health outcomes (improved sleep and
social interactions, and decreased anxiety and depressive symptoms).The purpose of this study
is to describe the nature and degree of clinical benefit of the intervention on bereaved
parents' health outcomes.
Description:
ADAPT, is multi-modal intervention that promotes a targeted approach to individual parental
bereavement experiences. ADAPT is based on the theoretical foundations of the Adaptive
Leadership (AL) framework. ADAPT, incorporates varied self-management strategies including:
A: Asking for assistance (option to connect with child's healthcare team); DA: Developing
Adaptive ability (self-management tools: e.g. stress reduction, legacy building); P:
Accessing Pertinent online resources (grief support networks/websites); and T: Tracking one's
health (self-administered surveys for grief, sleep, anxiety, and depression). Parents can
download ADAPT on any digital device (phones/computers) using weblink.
B. Study Purpose and Objective(s)
The purpose of this study is to describe the nature and degree of clinical benefit of the
intervention on bereaved parents' health outcomes. The Specific Aims are:
Aim 1: Assess the acceptability and feasibility of the ADAPT intervention components.
Acceptability will be assessed with a modified standardized acceptability survey and
cognitive interviews. Feasibility will be assessed by accrual (recruitment), attrition, and
intervention engagement (i.e., frequency, duration, and interaction). Intervention engagement
data will be obtained via Google analytics and cognitive interviews.
Hypothesis 1.1: ADAPT is acceptable to participants (> 80% acceptability based on survey).
Hypothesis 1.2: Delivery of ADAPT is feasible in terms of accrual (N=30), attrition (15%),
and intervention engagement (minimally accessed 3 times for >15 minutes and used at least 2
self-management strategies) Aim 2: Determine if the use of the ADAPT intervention components
results in a clinically meaningful change in grief integration (Brief Grief Questionnaire)
and bereaved parents' health outcomes (Visual Analogue Scale for overall health and PROMIS
surveys for sleep, social isolation, anxiety, and depression). Hypothesis 2.1: After
completing the ADAPT intervention, participants will demonstrate improvement in health
outcome scores when compared to baseline (T0).
Design: quasi-experimental, treatment-only design. Sample: N=35 parents of children who have
died while being followed for care at either Akron Children's Hospital or Cardinal Glennon
Children's hospital.
Recruitment: Participants will be recruited into two groups. Group 1 will be parents whose
child died 4 weeks (+ 2 weeks) prior; Group 2 will be parents whose child died three months
(+/- 2 weeks) prior to enrollment. Either a mother or a father for any one child will be
recruited.
For both the groups, a Study Information Sheet will be included in each bereavement packet
sent or mailed home, at either 4 week (group 1) or 3 months (group 2) after the child has
died. This Study Information Sheet will have a study-specific phone number and email address
for a clinical research coordinator, through which the parent can immediately opt in or opt
out. If there is no response following one to two weeks after the bereavement packet was
sent, the bereaved parents will be contacted by study staff via telephone to assess interest,
discuss the study, and answer any questions they may have. If the parent agrees to
participate, econsent will be completed using REDCap. After completing the econsent,
participants will have access to ADAPT and will be provided a REDCap survey link to allow
self-completion of baseline questionnaires (T0) (see Table 1). Three months after completing
the intervention (T1), participants will again be provided a REDCap survey link to
post-intervention questionnaires (see Table.1). At that time, a semi-structured cognitive
interview with participants will be scheduled. The interviews will be conducted via telephone
and will be recorded, transcribed, and verified for accuracy by the study team.